Busulfan Pharmacokinetics and Precision Dosing: Are Patients with Fanconi Anemia Different?

It is well known that pharmacokinetics (PK) guided busulfan (BU) dosing increases engraftment rates and lowers hepatotoxicity in patients undergoing hematopoietic cell transplantation (HCT). However, there are no published PK data in patients with Fanconi anemia (FA) who are known to have baseline D...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Biol Blood Marrow Transplant
Autores principales: Mehta, Parinda A., Emoto, Chie, Fukuda, Tsuyoshi, Seyboth, Brian, Teusink-Cross, Ashley, Davies, Stella M., Wilhelm, Jamie, Fuller, Kirsten, Vinks, Alexander A., Boulad, Farid
Formato: Artigo
Lenguaje:Inglês
Publicado: 2019
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7219959/
https://ncbi.nlm.nih.gov/pubmed/31326610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2019.07.014
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares